Evidence map›Paper›PMID 41407462›Full record

ArticleZhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi2025

[Autologous hematopoietic stem cell transplantation with TBE conditioning in patients with primary central nervous system lymphoma].

J L Chen, Y Ma, R Q Zhao, X B Xiao, X L Chen, S Z Yuan, S H Zhao, Y Lu, H H Gao, Y Q Wang and 5 more

Abstract readEnglish Abstract
PubMed Full text at PMC Publisher
In one paragraph

Article in Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

J L ChenDepartment of Lymphoma & Plasma Cell Disease, Senior Department of Hematology, the Fifth Medical Center of PLA General Hospital, Beijing 100071, China.
Y MaDepartment of Lymphoma & Plasma Cell Disease, Senior Department of Hematology, the Fifth Medical Center of PLA General Hospital, Beijing 100071, China.
R Q ZhaoDepartment of Lymphoma & Plasma Cell Disease, Senior Department of Hematology, the Fifth Medical Center of PLA General Hospital, Beijing 100071, China.
X B XiaoDepartment of Lymphoma & Plasma Cell Disease, Senior Department of Hematology, the Fifth Medical Center of PLA General Hospital, Beijing 100071, China.
X L ChenDepartment of Lymphoma & Plasma Cell Disease, Senior Department of Hematology, the Fifth Medical Center of PLA General Hospital, Beijing 100071, China.
S Z YuanDepartment of Lymphoma & Plasma Cell Disease, Senior Department of Hematology, the Fifth Medical Center of PLA General Hospital, Beijing 100071, China.
S H ZhaoDepartment of Lymphoma & Plasma Cell Disease, Senior Department of Hematology, the Fifth Medical Center of PLA General Hospital, Beijing 100071, China.
Y LuDepartment of Lymphoma & Plasma Cell Disease, Senior Department of Hematology, the Fifth Medical Center of PLA General Hospital, Beijing 100071, China.
H H GaoDepartment of Lymphoma & Plasma Cell Disease, Senior Department of Hematology, the Fifth Medical Center of PLA General Hospital, Beijing 100071, China.
Y Q WangDepartment of Lymphoma & Plasma Cell Disease, Senior Department of Hematology, the Fifth Medical Center of PLA General Hospital, Beijing 100071, China.
H YinDepartment of Lymphoma & Plasma Cell Disease, Senior Department of Hematology, the Fifth Medical Center of PLA General Hospital, Beijing 100071, China.
N N ChengDepartment of Lymphoma & Plasma Cell Disease, Senior Department of Hematology, the Fifth Medical Center of PLA General Hospital, Beijing 100071, China.
P FengDepartment of Lymphoma & Plasma Cell Disease, Senior Department of Hematology, the Fifth Medical Center of PLA General Hospital, Beijing 100071, China.
X R BaiDepartment of Lymphoma & Plasma Cell Disease, Senior Department of Hematology, the Fifth Medical Center of PLA General Hospital, Beijing 100071, China.
W R HuangDepartment of Lymphoma & Plasma Cell Disease, Senior Department of Hematology, the Fifth Medical Center of PLA General Hospital, Beijing 100071, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Central Nervous System NeoplasmsHematopoietic Stem Cell TransplantationLymphomaTransplantation ConditioningAdultAgedBusulfanEtoposideFemaleHumansMaleMiddle AgedRetrospective StudiesThiotepaTransplantation, AutologousYoung AdultBusulfanEtoposideThiotepaBusulfanEtoposideHematopoietic stem cell transplantationPrimary central nervous system lymphomaThiotepa

Identifiers

PMID41407462
PMCPMC12708950

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.